Statistics for Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease

Total visits

views
Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease 306

Total visits per month

views
October 2024 0
November 2024 0
December 2024 0
January 2025 1
February 2025 0
March 2025 0
April 2025 0

File Visits

views
Farlow_2015_long-term.pdf 201
java.util.UUID:f31fb811-e02f-47f6-9bf3-c8e8f262e4d7 54
java.util.UUID:828b5736-6b5c-42a8-a8bd-f78f4672e32b 5
java.util.UUID:69c190c4-0e56-48de-b6cf-5484b826612a 4

Top country views

views
United States 211
Germany 19
South Korea 12
United Kingdom 5
Ukraine 5
Canada 3
China 3
Spain 3
Russia 3
Australia 2
Switzerland 2
Singapore 2
Austria 1
Belgium 1
France 1
Ireland 1
Malaysia 1
Netherlands 1
Portugal 1
Turkey 1

Top city views

views
Wilmington 56
Ann Arbor 23
Fairfield 19
Kiez 14
Lake Mary 10
San Francisco 10
Seoul 9
Houston 8
Jacksonville 7
Cambridge 6
Kiev 5
White Plains 5
Philadelphia 4
Washington 4
Dearborn 3
Munich 3
Saint Petersburg 3
Concord 2
Daejeon 2
Dublin 2
Renens 2
Singapore 2
Toronto 2
Warrington 2
Alexandria 1
Antalya 1
Barcelona 1
Beijing 1
Bolton 1
Brooklyn 1
Daebang 1
Falls Church 1
Frankfurt Am Main 1
Gunzenhausen 1
Lake Forest 1
Leuven 1
Lilydale 1
Lisbon 1
Madrid 1
Melbourne 1
Murcia 1
Norwalk 1
Queen Creek 1
Roubaix 1
Scottsdale 1
Seremban 1
Vancouver 1
Vienna 1
Wageningen 1